Skip to content

Evaluation of the effect of TECAR and exercise therapy in patients with chronic nonspecific back pain

The effect of resistive capacitive electric transfer method and flexibility exercises on pain, range of motin, disability and quality of life in patients with chronic nonspecific low back pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220227054142N1
Enrollment
50
Registered
2022-04-18
Start date
2022-04-09
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: chronic nonspecific low back pain. Condition 2: Chronic nonspecific back pain. M54.5

Interventions

Intervention 1: Intervention group:. Intervention 2: Control group:.

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Pain in the lower back for at least 3 months if the exact cause is not known • The person has the ability to do exercises • The person is willing to do exercises and therapy sessions

Exclusion criteria

Exclusion criteria: No acute back pain (at least 3 months after pain) Infection in the lumbar region Fracture or tumor History of lumbar surgery Pace Maker or any electrical device in the body Severe deformity in the lower limbs or spine such as scoliosis Specific diseases of the spine such as severe osteoporosis or ankylosing spondylitis Neurological problems such as stroke or other problems that deprive a person of the ability to perform exercises and tests Lack of understanding and inability of the questionnaire

Design outcomes

Primary

MeasureTime frame
Pain: The effect of resistive capacitive electric transfer method and flexibility exercises in patients with chronic nonspecific low back pain. Timepoint: Before the start of the study - at the end of 10 treatment sessions - one month (30 days) days after the end of treatment - three months after the end of treatment (90 days). Method of measurement: Visual-analog scale.;Disability: Any limitation or inability to perform an activity in the normal range that is possible for a normal and healthy person to perform. Timepoint: Before the start of the study - at the end of 10 treatment sessions - one month (30 days) days after the end of treatment - three months after the end of treatment (90 days). Method of measurement: Oswestry Disability Index (ODI).

Secondary

MeasureTime frame
Quality of life :: Quality of life is the perception of each person of their health status and the degree of satisfaction with this situation. Timepoint: Before the start of the study - at the end of 10 treatment sessions - one month (30 days) days after the end of treatment - three months after the end of treatment (90 days). Method of measurement: Persian version of the 12-item SF-12 questionnaire.;Range of motion: The amount of movement in a joint that depends on the bone structure and physiological characteristics of the connective tissue around the joint. Timepoint: Before the start of the study - at the end of 10 treatment sessions - one month (30 days) days after the end of treatment - three months after the end of treatment (90 days). Method of measurement: ?? ????? ?? ??? ???? ??? ?? ????? ???? ???? ? ???? ??? ?? ???? ???? ?? ????? ????? ????? ?? ??? ?? ?? ??? ? ???? ? ??? ??????? ?? ???? ?????? ????? ?? ???.;Range of motion Bending forward: The amount of movement in a joint that depends on the bone structure and physiological characteristics of the connective tissue around the joint. Timepoint: Before the start of the study - at the end of 10 treatment sessions - one month (30 days) days after the end of treatment - three months after the end of treatment (90 days). Method of measurement: Modified Schober Index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Jarghouei

Iran University of Medical Sciences

ptmehdi.j1995@gmail.com+98 31 5777 0545

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026